Work

A phase I trial of IMC A12 and temsirolimus in children with refractory solid tumors: A Children’s Oncology Group study.

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.15_suppl.9541

Authors: Maryam Fouladi, John Peter Perentesis, Lars M. Wagner, Ashish M Ingle, George Thomas, Darcy A. Krueger, Peter Houghton, A.A. Vinks, L. Austin Doyle, Brenda Weigel, Susan Blaney

Institutions: Cincinnati Children's Hospital Medical Center, Children's Oncology Group, Nationwide Children's Hospital, National Cancer Institute, University of Minnesota

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2585977242

Cites:

Cited by: 2

Related to: 10